INS and type 2 diabetes mellitus: Pioglitazone has been widely used for the treatment of type 2 diabetes (T2D) for its potent insulin sensitizing effect that preserves beta-cell function and causes durable reduction in HbA1c, amid some negative side effects such as weight gain, fluid retention, and increased fracture risk (1–6).